From: Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
Treatment modality | % Pyknotic cells (p value) | % TUNEL positive cells (p value) | % Cleaved PARP positive cells (p value) |
---|---|---|---|
AZ | 8 ± 0.6 (p < 0.001) | 7 ± 0.66 (p = 0.0015) | 12 ± 0.7 (p < 0.01) |
MS-275 | 36 ± 0.45 | 56 ± 0.33 (p < 0.001) | 50 ± 0.23 (p < 0.001) |
AZ + MS-275 | 51 ± 0.83 (p < 0.001) | 82 ± 0.76 (p < 0.001) | 69 ± 0.35 (p < 0.001) |